U.S. Trade Distributors Stock News

In recent weeks, Dollar General has drawn conflicting analyst reactions, with Guggenheim reiterating a positive stance while Rothschild & Co Redburn shifted to a more cautious view due to concerns about sales, margins and new store returns. This split in opinion comes as Dollar General has recently outperformed the broader market despite a multi-year decline in earnings per share alongside rising revenue, highlighting tension between its operational momentum and profitability trends. We’ll...

European Commission approves MYQORZO (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy in adults across the EU. The decision follows Phase 3 clinical data and adds a new treatment option for eligible patients in Europe. This approval marks a fresh regulatory milestone for Cytokinetics (NasdaqGS:CYTK) outside the US. Cytokinetics, listed on NasdaqGS:CYTK, focuses on muscle biology therapies, and MYQORZO now gives it an approved cardiovascular product in Europe for...

In February 2026, Expedia Group reported fourth-quarter 2025 results showing revenue of US$3,547 million and net income of US$205 million, alongside full-year revenue of US$14.73 billion and net income of US$1.29 billion, while issuing 2026 revenue guidance of US$15.60–US$16.00 billion, raising its quarterly dividend to US$0.48 per share, and updating investors on a completed US$3.43 billion share buyback that retired 16.89% of its stock. Management highlighted that B2B bookings growth, a...

Charles River Laboratories International (CRL) has just posted its FY 2025 third quarter numbers, with revenue of US$1,004.9 million and basic EPS of US$1.11, against a backdrop where trailing 12 month results still reflect a net loss on EPS. The company has seen quarterly revenue move between US$984.2 million and US$1,032.1 million over the first half of FY 2025, with basic EPS ranging from US$0.50 to US$1.06. Trailing 12 month revenue sits at about US$4.0 billion paired with a net loss of...

Macerich (MAC) just released its fourth quarter and full year 2025 results, giving investors fresh numbers on sales, revenue, and net losses that help explain recent stock price moves. See our latest analysis for Macerich. Macerich’s recent earnings release and dividend affirmation have come alongside a clear shift in sentiment, with the 90 day share price return of 18.21% and a three year total shareholder return of 77.28% signalling positive momentum despite a slightly negative one year...

If you are wondering whether Hewlett Packard Enterprise (HPE) is attractively priced right now, this article walks through what the current share price could mean for long term investors. HPE recently closed at US$21.55, with returns of 1.3% over the past year, a 48.8% gain over 3 years, and a 68.3% gain over 5 years, despite a 9.5% decline over the last 7 days and a 10.8% decline year to date. Recent coverage has focused on HPE's role as a major enterprise technology provider and how...

Michael Dell’s investment firm MSD Capital recently disclosed in its fourth-quarter 2025 13F filing that it cut its Hayward Holdings stake by 223,833 shares, reducing its position by about 36.81%. This sizeable trim by a high-profile investor puts renewed attention on how concentrated institutional ownership can influence sentiment around Hayward’s pool equipment business. We’ll now examine how MSD Capital’s reduced stake reshapes Hayward’s investment narrative, particularly around...

Compass stock snapshot after recent price moves Compass (COMP) has drawn fresh attention after recent share price swings, with a 3.6% gain over the past day contrasting with weaker performance over the past week and month. See our latest analysis for Compass. That 3.6% 1 day share price return comes after a 18.7% 30 day share price decline, while the 3 year total shareholder return of around 7x suggests the longer term story has been much stronger than recent trading. If Compass’s swings have...

Cullen/Frost Bankers (NYSE:CFR) highlights a robust dividend record, with a pattern of regular increases that outpaces many peers. The company presents this dividend profile as evidence of sustained financial strength and a positive outlook for future earnings. The bank indicates potential for further dividend growth, reinforcing its appeal for income focused shareholders. Cullen/Frost Bankers, a Texas based regional bank, is putting its dividend front and center at a time when many...

ColdQuanta (INFQ) remains in focus for investors after recent trading left the share price at US$14.71, with short term moves including a 5.6% one day decline and mixed month and past 3 months returns. See our latest analysis for ColdQuanta. Those recent moves sit within a wider pattern where the 90 day share price return of 11.2% contrasts with a 14.7% 1 month share price decline. This suggests that momentum has cooled after an earlier upswing. If ColdQuanta’s quantum focus has your...

Hycroft Mining Holding (NasdaqCM:HYMC) reported a 55% increase in gold and silver mineral resources. The company identified new high grade silver systems with potential for underground mining. Hycroft also announced upcoming changes to its board, including the departure of a key member for health reasons. Hycroft Mining focuses on gold and silver production and development, so a 55% rise in mineral resources directly affects how investors think about the company’s asset base. The discovery...

Avantor (AVTR) has drawn fresh attention after recent price moves left the stock with a negative return over the past year and a value score of 5, prompting investors to reassess its risk reward profile. See our latest analysis for Avantor. Despite a 2.43% 1 day share price gain, Avantor’s 30 day share price return of a 23.77% decline and 1 year total shareholder return of a 47.57% loss point to fading momentum and a tougher recent backdrop for investors. If Avantor’s recent swings have you...

Robotti Value Investors recently highlighted Tidewater (TDW) in its fourth quarter 2025 letter, pointing to the company’s stronger balance sheet, consolidated fleet, and tighter offshore energy supply-demand conditions supporting renewed pricing power. See our latest analysis for Tidewater. Tidewater’s recent investor attention from Robotti comes alongside strong price momentum, with a 24.35% 1 month share price return and a 36.78% year to date share price return. The 5 year total shareholder...

If you are wondering whether Community Financial System is priced fairly at around US$63.92, taking a closer look at its valuation metrics can help you see what the market might be factoring in. The stock has had mixed short term moves, with a 3.6% decline over the last 7 days, a 3.5% return over the last 30 days, and a 10.0% return year to date, while the 1 year return sits at 1.3% and the 3 year return at 18.8%. Recent coverage of Community Financial System has focused on its position...

Fluor Corporation recently reported fourth-quarter 2025 results showing revenue of US$4.18 billion, a net loss of US$1.57 billion, and full-year 2025 sales of US$15.50 billion alongside continued share repurchases and NuScale stake monetization. At the same time, Fluor has been chosen for large energy and mining assignments, including Centrus Energy’s multi-billion-dollar uranium enrichment expansion and the Donlin Gold bankable feasibility study, while reaffirming a grow-and-execute focus...

Roper Technologies (ROP) is back in focus after its Q4 2025 report, where revenue growth and an adjusted earnings beat were paired with a decline in net earnings and more cautious guidance. See our latest analysis for Roper Technologies. The Q4 update landed against a weak backdrop for the stock, with a 30 day share price return of a 21.3% decline and a year to date share price return of a 24.6% decline, while the 1 year total shareholder return is down 42.9%. This points to fading momentum...

In February 2026, Otter Tail Corporation reported its fourth quarter and full-year 2025 results, showing higher quarterly sales of US$149.71 million but lower net income of US$51.77 million, alongside full-year diluted EPS from continuing operations of US$6.55 and new 2026 diluted EPS guidance of US$5.22 to US$5.62. The company also lifted its dividend for the 88th consecutive year and outlined a US$1.90 billion-plus capital plan centered on renewables, transmission, and battery storage, to...

In early February 2026, Globe Life Inc. raised its full-year 2026 earnings guidance, projecting net operating income between $14.95 and $15.65 per diluted share, signaling management’s updated expectations for the business. This guidance increase offers investors a clearer benchmark for assessing how Globe Life’s capital deployment, underwriting discipline, and distribution initiatives are translating into expected profitability. We’ll now examine how Globe Life’s higher 2026 earnings...

Vertex Pharmaceuticals (NasdaqGS:VRTX) and CRISPR Therapeutics are ramping up patient treatments with Casgevy, a gene-editing therapy. Casgevy is approved for sickle cell disease and beta thalassemia, marking a key step in bringing gene-editing into routine clinical use. The current focus is on moving from approval to broader real-world deployment across eligible patient populations. For you as an investor, Casgevy sits at the intersection of Vertex's established role in serious diseases...

Recent analysis shows that over the past two years Greenbrier Companies has faced declining unit sales, softer demand, a 14% gross margin that trails peers, and free cash flow shortfalls, all of which have prompted fresh scrutiny of its operating model. A key concern is that weaker margins and cash generation may limit Greenbrier’s ability to fund marketing, innovation, and other investments needed to strengthen its competitive position. We’ll now examine how concerns about declining unit...

TG Therapeutics (TGTX) is back in focus after publishing five year data from the open label extension of its Phase 3 ULTIMATE I and II BRIUMVI trials in relapsing multiple sclerosis, highlighting durable efficacy and safety. See our latest analysis for TG Therapeutics. The latest BRIUMVI data arrive as TG Therapeutics trades at US$29.23, with a 7 day share price return of 1.42% but a 30 day share price return decline of 4.38%. A 3 year total shareholder return of 72.96% contrasts with a 5...

Integer Holdings Corporation has released its fourth-quarter and full-year 2025 results, reporting higher quarterly sales of US$472.06 million and net income of US$48.61 million, alongside full-year sales of US$1.85 billion but lower annual net income of US$102.81 million compared with the prior year. The company also issued 2026 guidance calling for US$1.83–1.88 billion in sales and diluted EPS of US$3.53–4.01, framing investor expectations amid earlier guidance concerns and ongoing...

Occidental Petroleum (NYSE:OXY) has launched a series of cash tender offers for certain senior notes and debentures. The company is using proceeds from the completed US$9.7b OxyChem divestiture to reduce debt. Alongside the liability actions, Occidental has announced an 8% quarterly dividend increase. Occidental Petroleum, a large upstream and integrated energy company, is in a new phase of balance sheet repair following its Anadarko acquisition period. The combination of debt tenders and a...

Axogen recently confirmed it met the Minervini Trend Template, signaling an institution-led uptrend supported by improving earnings, sales trends, and analyst estimate revisions. At the same time, management’s participation in multiple high-profile investor conferences has increased visibility around Axogen’s shift toward maintained profitability and growth-focused execution. We’ll now explore how Axogen’s institution-backed uptrend and upcoming investor conference participation may...